IONS
Ionis Pharmaceuticals Inc
44.00$
+1.1%
vs. previous close
Closing price · As of: Oct 6, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -93.4% | -63.0% | -88.5% | -142.8% | -62.2% | -11.6% | -117.7% | -191.0% | -238.7% | -153.8% | -358.2% | 61.9% | 197.8% | -89.2% | -58.6% | -115.9% | 1.8% | 43.1% | 2.9% | 7.4% | -32.3% | 33.9% | 100.5% | 30.8% | 4.9% | 3.8% | -46.7% | -39.0% | -71.0% | -28.5% | |
| 11.5% | 9.8% | 11.0% | 15.3% | 14.9% | 13.1% | 12.9% | 24.5% | 28.6% | 24.1% | 48.6% | 11.6% | 6.4% | 9.3% | 8.5% | 11.9% | 10.5% | 6.6% | 4.4% | 3.6% | 2.6% | 1.6% | 2.1% | 1.4% | 2.4% | 2.4% | 3.8% | 2.9% | 2.8% | 2.4% | |
| – | – | – | – | – | 8.6% | -3.7% | – | 2.1% | -1.4% | 38.7% | 17.0% | 14.1% | 11.0% | 11.2% | 9.9% | 8.4% | 7.8% | 14.7% | 20.9% | 20.8% | 16.7% | 21.9% | 13.1% | 31.6% | 14.9% | 17.1% | 13.4% | 18.5% | 14.2% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | 15.2% | 11.2% | -4.2% | 6.4% | 3.3% | 21.6% | 22.6% | 16.7% | -26.5% | 14.4% | 72.5% | 16.2% | 17.5% | – | – | – | |
| 12.3% | 21.1% | -18.9% | -29.2% | -2.4% | 47.3% | -22.5% | -48.5% | -56.8% | -22.3% | 17.4% | 91.9% | 196.7% | -85.6% | -38.2% | -68.0% | 49.2% | 58.4% | 2.4% | 7.3% | -43.7% | 8.5% | 83.3% | -15.0% | -10.1% | -14.0% | 1.3% | -9.8% | -29.7% | -5.4% | |
| 4.0% | 10.7% | 11.2% | 14.2% | 4.4% | 17.4% | 45.9% | 15.1% | 8.3% | 1.1% | 17.2% | 8.6% | 15.9% | 13.4% | 16.2% | 11.1% | 5.1% | 3.6% | 5.2% | 4.1% | 3.3% | 7.4% | 2.9% | 3.2% | 5.6% | 2.2% | 3.4% | 3.6% | 6.4% | 5.4% | |
| -49.8% | -46.5% | 23.2% | -23.3% | -256.0% | -269.3% | -75.3% | -30.2% | 196.4% | 1.3% | -219.5% | -95.4% | -218.5% | -174.6% | 21.8% | 111.9% | 17.6% | -173.6% | -38.7% | -21.2% | 16.3% | -69.7% | -155.0% | -3.7% | 37.7% | 24.0% | -44.7% | -27.2% | -19.0% | -29.4% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | – | 14.7% | – | 2.1% | 1.9% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | 4.0% | 3.6% | 9.3% | 160.4% | 10.8% | 8.8% | 3.6% | 49.2% | 79.4% | -3.1% | -12.4% | -2.1% | -1.9% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | -4.0% | -5.9% | 20.1% | -7.5% | 16.4% | -0.2% | -0.9% | 10.9% | 16.2% | -2.0% | 43.0% | 51.6% | -8.6% | 11.0% | -6.3% | 53.2% | |
| 101.3% | 112.2% | 38.5% | 188.5% | 329.8% | 445.0% | 161.6% | 83.7% | 28.5% | 93.7% | 1,005.9% | 74.8% | 100.4% | 166.1% | 4.3% | -0.7% | 38.3% | 154.6% | 27.8% | 8.7% | 3.3% | 44.6% | 79.4% | 8.9% | -81.8% | 30.3% | -9.4% | 81.8% | 67.8% | 71.6% | |
| 101.3% | 112.2% | 38.5% | 22.7% | 11.6% | 164.1% | -31.4% | -137.5% | -13.8% | -58.8% | 428.2% | 41.3% | 79.6% | -97.6% | -32.5% | -4.6% | 57.8% | 24.1% | -7.9% | -5.0% | -12.7% | 8.7% | 24.9% | 36.0% | -39.2% | 58.2% | -100.9% | 15.6% | -22.3% | 13.8% | |
| -97.4% | -73.7% | -99.7% | -156.9% | -66.7% | -29.0% | -163.7% | -206.1% | -247.0% | -154.9% | -375.4% | 53.3% | 181.9% | -102.6% | -74.8% | -127.0% | -3.2% | 39.5% | -2.3% | 3.3% | -35.7% | 26.5% | 97.6% | 27.6% | -0.7% | 1.6% | -50.1% | -42.6% | -77.5% | -33.9% |
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.